2016

IBM, Pfizer use Watson to accelerate immuno-oncology research

Friday, December 2, 2016

IBM Watson Health and Pfizer have announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer. Pfizer is one of the first organizations worldwide to deploy Watson for Drug Discovery, and the first to customize the cloud-based cognitive tool—tapping in to Watson’s machine learning, natural language processing, and other cognitive reasoning technologies to support the identification of new drug targets, combination therapies for study, and patient selection strategies in immuno-oncology.

[Read More]

AiCure wins 2016 Scrip Award

Thursday, December 1, 2016

AiCure, which uses artificial intelligence (AI) on mobile devices to visually confirm medication ingestion, are the winners of the 2016 Scrip Award in the category of Best Technological Development in Clinical Trials. Judges from industry, academia and finance rewarded the artificial intelligence platform for its unique contribution in driving efficiencies and quality data in clinical research.

[Read More]

VA, Prostate Cancer Foundation partner to expand clinical research

Thursday, December 1, 2016

The Department of Veterans Affairs (VA) has announced an important and substantial partnership with the Prostate Cancer Foundation (PCF) to prevent, screen and promote research to speed the development of treatments and cures for prostate cancer among Veterans. Announcement of the partnership was made during Launch Pad: Pathways to Cancer InnoVAtion, a joint VA/PCF summit that brings together world-class oncology experts, corporate and nonprofit partners to discuss research, big data, technology and clinical solutions to advance screening, diagnostics and care coordination for cancer and to promote the implementation of best practices across the VA healthcare system. 

[Read More]

BioCision forms MedCision

Thursday, December 1, 2016

BioCision, a life science research and development company that standardizes basic laboratory processes, has announced the formation of MedCision, an independent company focused on automation of preclinical and clinical processes.

[Read More]